The Life Sciences team advised ElevateBio on its $525 million Series C financing.
ElevateBio is a cell and gene therapy technology company focused on powering transformative cell and gene therapies.
With this financing, ElevateBio will continue to develop and expand its technology platforms, build upon its network of process development and GMP manufacturing capacity, and advance an increasing number of industry partnerships, while also continuing to develop its own highly innovative cell and gene therapies.
The Goodwin team was led by Danielle Lauzon, Gaby Morales-Rivera, Katie Hand, and Alexandra Haas, and included Dan Karelitz, Richard Matheny, Carrie Miller, Justin Pierce, Steve Tjoe, and Mark Burnett, with invaluable assistance from Jackie Klosek, Scott Zilora, Jay Yaworsky, and Kathy Georgian.
For more details, read the press release.